tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ICLR Stock Latest News

ICON plc Announces Third Quarter 2025 Earnings Call
Company AnnouncementsICON plc Announces Third Quarter 2025 Earnings Call
5d ago
6K
ICLR
Icon price target lowered to $183 from $209 at TD Cowen
PremiumThe Fly
Icon price target lowered to $183 from $209 at TD Cowen
18d ago
ICLR
Icon management to meet with Mizuho
PremiumThe Fly
Icon management to meet with Mizuho
19d ago
ICLR
Lululemon downgraded, Dick’s Sporting upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Lululemon downgraded, Dick’s Sporting upgraded: Wall Street’s top analyst calls
21d ago
H
RS
Icon downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Icon downgraded to Hold from Buy at Jefferies
21d ago
ICLR
Buy Rating Affirmed for Icon Amid CEO Transition and Market Challenges
PremiumRatingsBuy Rating Affirmed for Icon Amid CEO Transition and Market Challenges
22d ago
ICLR
ICON Plc and Zealand Pharma’s Petrelintide Study: A Key Update for Investors
Premium
Company Announcements
ICON Plc and Zealand Pharma’s Petrelintide Study: A Key Update for Investors
23d ago
ICLR
ICON plc’s Latest Study on Kedrion IVIG 10% for Chronic ITP: A Market Perspective
Premium
Company Announcements
ICON plc’s Latest Study on Kedrion IVIG 10% for Chronic ITP: A Market Perspective
23d ago
ICLR
Strategic Leadership Transition and Market Resilience Underpin Buy Rating
PremiumRatings
Strategic Leadership Transition and Market Resilience Underpin Buy Rating
23d ago
ICLR
ICON plc Reaffirms 2025 Financial Guidance Amid CEO Transition
PremiumCompany Announcements
ICON plc Reaffirms 2025 Financial Guidance Amid CEO Transition
26d ago
6K
ICLR
Icon confirms financial guidance for FY25
PremiumThe Fly
Icon confirms financial guidance for FY25
26d ago
ICLR
ICON Announces CEO Transition Effective October 1, 2025
PremiumCompany Announcements
ICON Announces CEO Transition Effective October 1, 2025
26d ago
6K
ICLR
Icon CEO Steve Cutler to retire, Barry Balfe to succeed
PremiumThe FlyIcon CEO Steve Cutler to retire, Barry Balfe to succeed
26d ago
ICLR
Icon upgraded to Buy from Neutral at Rothschild & Co Redburn
Premium
The Fly
Icon upgraded to Buy from Neutral at Rothschild & Co Redburn
27d ago
ICLR
Icon price target raised to $224 from $222 at Baird
Premium
The Fly
Icon price target raised to $224 from $222 at Baird
28d ago
ICLR
ICON plc Announces Participation in September 2025 Investor Conferences
PremiumCompany Announcements
ICON plc Announces Participation in September 2025 Investor Conferences
28d ago
6K
ICLR
AstraZeneca and Icon Plc’s Study on ATTR Amyloidosis: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca and Icon Plc’s Study on ATTR Amyloidosis: Key Insights for Investors
1M ago
AZN
ICLR
ICON plc Releases Interim Financial Statements for 2025
PremiumCompany Announcements
ICON plc Releases Interim Financial Statements for 2025
1M ago
6K
ICLR
Icon downgraded to Neutral from Buy at Citi
PremiumThe Fly
Icon downgraded to Neutral from Buy at Citi
1M ago
ICLR
Icon’s Resilience and Growth Potential: Buy Rating Despite BARDA Trial Delays
PremiumRatingsIcon’s Resilience and Growth Potential: Buy Rating Despite BARDA Trial Delays
2M ago
ICLR
Icon suspends COVID vaccine study after BARDA notice to sponsor
Premium
The Fly
Icon suspends COVID vaccine study after BARDA notice to sponsor
2M ago
ICLR
ICON plc Halts COVID Vaccine Study Following BARDA Notice
Premium
Company Announcements
ICON plc Halts COVID Vaccine Study Following BARDA Notice
2M ago
6K
ICLR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >